Key regions: Australia, Italy, France, South Korea, Brazil
Myanmar, a country with a population of over 54 million people, has been experiencing a significant increase in its healthcare sector, particularly in the vaccines market.
Customer preferences: Myanmar has been focusing on improving its healthcare sector, and vaccines are an integral part of it. The country has been investing heavily in immunization programs and has been successful in vaccinating its population against various diseases. The government has been working towards increasing awareness about the importance of vaccination, which has led to a rise in demand for vaccines in the country.
Trends in the market: The vaccines market in Myanmar has been growing steadily, with a rise in demand for various types of vaccines. The country has been focusing on introducing new vaccines and expanding its immunization program to cover a larger population. The rise in demand for vaccines can be attributed to the increasing awareness about the importance of vaccination, the government's efforts to improve the healthcare sector, and the growing population in the country.
Local special circumstances: Myanmar has a unique set of circumstances that have contributed to the growth of its vaccines market. The country has been experiencing political and economic reforms, which have led to an increase in foreign investment and a rise in the country's GDP. As a result, there has been an increase in the purchasing power of the population, leading to a rise in demand for healthcare services, including vaccines. Additionally, the country has been facing various health challenges, such as outbreaks of infectious diseases, which have led to an increase in the demand for vaccines.
Underlying macroeconomic factors: Myanmar's economy has been growing steadily, with a rise in foreign investment and an increase in the country's GDP. The government has been focusing on improving the healthcare sector, which has led to an increase in demand for healthcare services, including vaccines. Additionally, the country has been experiencing various health challenges, such as outbreaks of infectious diseases, which have led to an increase in the demand for vaccines. The rise in demand for vaccines can also be attributed to the increasing awareness about the importance of vaccination and the government's efforts to improve the healthcare sector. In conclusion, Myanmar's vaccines market has been growing steadily, with a rise in demand for various types of vaccines. The country has been focusing on introducing new vaccines and expanding its immunization program to cover a larger population. The rise in demand for vaccines can be attributed to the increasing awareness about the importance of vaccination, the government's efforts to improve the healthcare sector, and the growing population in the country. Additionally, Myanmar's unique set of circumstances, such as political and economic reforms, health challenges, and an increase in foreign investment, have contributed to the growth of its vaccines market.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
